Telaprevir enhances ribavirin-induced anaemia through renal function impairment
L Cotte,
A Barrail-Tran,
C Vincent,
MA Valantin,
I Fournier,
K Lacombe,
Stephane CHEVALIEZ,
JP Aboulker,
AM Taburet,
JM Molina,
Antivir Ther. 01/01/2015;20(5) : 479-486 10.3851/IMP2929. 06/01/2015
Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial.
L Cotte,
J Braun,
C Lascoux-Combe,
C Vincent,
MA Valantin,
P Sogni,
K Lacombe,
D Neau,
H Aumaitre,
D Batisse,
P De Truchis,
A Gervais,
C Michelet,
P Morlat,
D Vittecoq,
I Rosa,
I Bertucci,
Stephane CHEVALIEZ,
JP Aboulker,
JM Molina,
Clin Infect Dis. 15/12/2014;59(12) : 1768-1776 10.1093/cid/ciu659. 18/08/2014
Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus.
N Jilg,
W Lin,
J Hong,
EA Schaefer,
D Wolski,
J Meixong,
K Goto,
C Brisac,
P Chusri,
DN Fusco,
Stephane CHEVALIEZ,
J Luther,
K Kumthip,
TJ Urban,
LF Peng,
GM Lauer,
RT Chung,
Hepatology. 01/04/2014;59(4) : 1250-1261 10.1002/hep.26653. 14/02/2014